000 01552 a2200409 4500
005 20250515122116.0
264 0 _c20080902
008 200809s 0 0 eng d
022 _a0014-2999
024 7 _a10.1016/j.ejphar.2008.04.019
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYeste-Velasco, Marc
245 0 0 _aGSK-3 beta inhibition and prevention of mitochondrial apoptosis inducing factor release are not involved in the antioxidant properties of SB-415286.
_h[electronic resource]
260 _bEuropean journal of pharmacology
_cJul 2008
300 _a239-43 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAminophenols
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aAntioxidants
_xpharmacology
650 0 4 _aApoptosis Inducing Factor
_xmetabolism
650 0 4 _aCells, Cultured
650 0 4 _aCerebellum
_xdrug effects
650 0 4 _aGlycogen Synthase Kinase 3
_xantagonists & inhibitors
650 0 4 _aGlycogen Synthase Kinase 3 beta
650 0 4 _aLithium
_xpharmacology
650 0 4 _aMaleimides
_xpharmacology
650 0 4 _aNeuroprotective Agents
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
700 1 _aFolch, Jaume
700 1 _aJiménez, Andres
700 1 _aRimbau, Victor
700 1 _aPallàs, Mercè
700 1 _aCamins, Antoni
773 0 _tEuropean journal of pharmacology
_gvol. 588
_gno. 2-3
_gp. 239-43
856 4 0 _uhttps://doi.org/10.1016/j.ejphar.2008.04.019
_zAvailable from publisher's website
999 _c17995968
_d17995968